Re:meat announces plans to expand cell-based beef production
Swedish cell-based meat company Re:meat has announced plans to construct Scandinavia’s “first-ever” cell-based beef plant and has unveiled the country's first prototype – a Swedish meatball.
The initial pilot plant will hold a capacity of 30 tonnes per year, with the company anticipating that over the next five years, Re:meat's commercial factories will be able to produce over 10,000 tonnes of cell-based beef annually.
Re:meat aims to significantly reduce production costs by replacing the majority of its media nutrients with hydrolysates sourced from low-cost feedstock and algae. It says it has developed a fetal bovine serum alternative that will allow it to direct its resources toward increasing production and to launch its large-scale production pilot facility next year.
The company uses cutting-edge sterilisation technology, which bypasses the high-cost processes and materials required by steam-in-place sterilisation methods – common in traditional biopharmaceutical factories.
Unlike other cell-based meat companies that focus on replicating costly biopharmaceutical factories to produce meat – an approach that Re:meat says leads to a severe mismatch in cost and scale – the company is committed to reducing both the cost of factories and production processes.
As part of its fundraising efforts, Re:meat is currently raising €1 million in investments and is also engaging large meat and food companies through a Scandinavian pioneer community. It hopes this will encourage clients to participate early in the production process to ensure customer-driven development and real-life demand for the capacity being built.